Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ferguson

Showing results (201-210 of 885) with videos related to

Pageof 89
Sort By:
Blood|February 1, 1990
Complexing of tissue plasminogen activator with PAI-1, alpha 2-macroglobulin, and C1-inhibitor: studies in patients with defibrination and a fibrinolytic state after electroshock or complicated laborB Bennett, A Croll, K Ferguson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 31, 2025
Exercise as a vital sign in cardiopulmonary disease: insights from wave intensity analysisScott K Ferguson, Kurt R Stenmark, David C Irwin
American Heart Journal|May 1, 1985
Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalaprilL J Riley, P H Vlasses, R K Ferguson
Environmental Health : a Global Access Science Source|May 10, 2019
Fetal growth in environmental epidemiology: mechanisms, limitations, and a review of associations with biomarkers of non-persistent chemical exposures during pregnancyElizabeth M Kamai, Thomas F McElrath, Kelly K Ferguson
Chest|September 1, 1991
The thoracic vent. Clinical experience with a new device for treating simple pneumothoraxS L Samelson, E M Goldberg, M K Ferguson
Journal of Clinical Pharmacology|January 1, 1985
Academic-industrial clinical pharmacology: a working modelR K Ferguson, P H Vlasses, W B Abrams
The Annals of Thoracic Surgery|January 1, 1995
Recurrent spontaneous perforation of the esophagusL B Reeder, S E Warren, M K Ferguson
Advances in Surgery|January 1, 1988
Barrett's esophagusM K Ferguson, A G Little, D B Skinner
JAMA Pediatrics|November 20, 2013
Environmental phthalate exposure and preterm birthKelly K Ferguson, Thomas F McElrath, John D Meeker
Drug Intelligence & Clinical Pharmacy|July 1, 1985
The role of beta-blocking agents following myocardial infarctionP H Vlasses, H H Rotmensch, R K Ferguson
Pageof 89

Showing results (201-210 of 885) with videos related to

Sort By:
Pageof 89
Blood|February 1, 1990
Complexing of tissue plasminogen activator with PAI-1, alpha 2-macroglobulin, and C1-inhibitor: studies in patients with defibrination and a fibrinolytic state after electroshock or complicated laborB Bennett, A Croll, K Ferguson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 31, 2025
Exercise as a vital sign in cardiopulmonary disease: insights from wave intensity analysisScott K Ferguson, Kurt R Stenmark, David C Irwin
American Heart Journal|May 1, 1985
Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalaprilL J Riley, P H Vlasses, R K Ferguson
Environmental Health : a Global Access Science Source|May 10, 2019
Fetal growth in environmental epidemiology: mechanisms, limitations, and a review of associations with biomarkers of non-persistent chemical exposures during pregnancyElizabeth M Kamai, Thomas F McElrath, Kelly K Ferguson
Chest|September 1, 1991
The thoracic vent. Clinical experience with a new device for treating simple pneumothoraxS L Samelson, E M Goldberg, M K Ferguson
Journal of Clinical Pharmacology|January 1, 1985
Academic-industrial clinical pharmacology: a working modelR K Ferguson, P H Vlasses, W B Abrams
The Annals of Thoracic Surgery|January 1, 1995
Recurrent spontaneous perforation of the esophagusL B Reeder, S E Warren, M K Ferguson
Advances in Surgery|January 1, 1988
Barrett's esophagusM K Ferguson, A G Little, D B Skinner
JAMA Pediatrics|November 20, 2013
Environmental phthalate exposure and preterm birthKelly K Ferguson, Thomas F McElrath, John D Meeker
Drug Intelligence & Clinical Pharmacy|July 1, 1985
The role of beta-blocking agents following myocardial infarctionP H Vlasses, H H Rotmensch, R K Ferguson
Pageof 89